FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the...
FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yet
About this item
Full title
FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yet
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature reviews. Drug discovery, 2024-05, Vol.23 (5), p.328-328
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yet
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3022567116
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3022567116
Other Identifiers
ISSN
1474-1776,1474-1784
E-ISSN
1474-1784
DOI
10.1038/d41573-024-00056-w
